Back

Journal of Medical Virology

95 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Neutralizing response against E484K variant after original SARS-CoV-2 infection
2021-05-12 infectious diseases 10.1101/2021.05.07.21256803
#1 (21.6%)
Show abstract

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) variants, which are spreading in the United Kingdom (UK) and elsewhere, have been found in infected individuals in Japan. The virus mutates, to facilitate its life in the host, during the process of repeated proliferation in the body of the host, including humans. In other words, it is natural that a human-compatible mutant strain always predominates in infection and proliferation. As a result, the viral mutants acquire strong prolifer...

2
Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients
2020-11-13 infectious diseases 10.1101/2020.11.10.20228973
#1 (17.5%)
Show abstract

IntroductionCOVID 19 has been vastly spreading since December 2019 and the medical teams worldwide are doing their best to limit its spread. In the absence of a vaccine the best way to fight it is by detecting infected cases early and isolate them to prevent its spread. Therefore, a readily available, rapid, and cost-effective test with high specificity and sensitivity for early detection of COVID 19 is required. In this study, we are testing the diagnostic performance of a rapid antigen detecti...

3
Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers
2020-05-02 infectious diseases 10.1101/2020.04.28.20083139
#1 (17.3%)
Show abstract

BackgroundAsymptomatic carriers contribute to the spread of Coronavirus Disease 2019 (COVID-19), but their clinical characteristics, viral kinetics, and antibody responses remain unclear. MethodsA total of 56 COVID-19 patients without symptoms at admission and 19 age-matched symptomatic patients were enrolled. RNA of SARS-CoV-2 was tested using transcriptase quantitative PCR, and the total antibodies (Ab), IgG, IgA and IgM against the SARS-CoV-2 were tested using Chemiluminescence Microparticle...

4
Genomic Characterisation And Phylogenetic Analysis Of SARS-COV-2 In Italy
2020-03-20 epidemiology 10.1101/2020.03.15.20032870
#1 (17.3%)
Show abstract

This report describes the isolation, the molecular characterization and the phylogenetic analysis of the first three complete genomes of SARS-CoV-2 isolated from three patients involved in the first outbreak of COVID-19 in Lombardy, Italy. Early molecular epidemiological tracing suggests that SARS-CoV-2 was present in Italy weeks before the first reported cases of infection.

5
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR
2020-06-07 infectious diseases 10.1101/2020.06.05.20123745
#1 (16.8%)
Show abstract

BackgroundEarly 2020, a COVID-19 epidemic became a public health emergency of international concern. To address this pandemic broad testing with an easy, comfortable and reliable testing method is of utmost concern. The nasopharyngeal (NP) swab sampling is the reference method though hampered by international supply shortages. A new oropharyngeal/nasal (OP/N) sampling method was investigated using the more readily available throat swab. MethodsIn this prospective observational study 36 COVID-19...

6
Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in Colombia
2020-06-04 infectious diseases 10.1101/2020.06.02.20120782
#1 (16.8%)
Show abstract

IntroductionSARS-CoV-2 is a new member of the genus Betacoronavirus, responsible for the COVID-19 pandemics. The virus crossed the species barrier and established in the human population due to its ability to exploit the ACE receptor for virus entry, which is present and abundant in several tissues, including the lung and respiratory tract, gastrointestinal tract and hearth. Virus interaction with the cellular receptor is mediated by the surface protein, known as Spike. Another structural protei...

7
Performance of antigenic detection of SARS-CoV-2 in nasopharyngeal samples
2021-07-16 infectious diseases 10.1101/2021.07.12.21260263
#1 (16.4%)
Show abstract

ObjectivesSARS-CoV-2 virus detection on nasopharyngeal specimens to infected individuals has become a challenge for the COVID-19 pandemic outbreak. We aim at comparing the performance of antigenic detection of SARS-CoV-2 in nasopharyngeal samples via an immunochromatographic method to molecular detection via qRT-PCR. Materials and Methods47 nasopharyngeal exudates were collected from suspicious COVID-19 cases. The samples were performed both via the qualitative immuno-chromatographic method for...

8
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic
2020-07-07 infectious diseases 10.1101/2020.07.06.20147140
#1 (16.2%)
Show abstract

The aim of this study is the characterization and genomic tracing by phylogenetic analyses of 59 new SARS-CoV-2 Italian isolates obtained from patients attending clinical centres in North and Central Italy until the end of April 2020. All but one of the newly characterized genomes belonged to the lineage B.1, the most frequently identified in European countries, including Italy. Only a single sequence was found to belong to lineage B. A mean of 6 nucleotide substitutions per viral genome was o...

9
The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region, Italy
2020-11-30 infectious diseases 10.1101/2020.11.28.20237016
#1 (16.1%)
Show abstract

A new SARS-CoV-2 clade (GV) characterized by S substitution A222V, first reported from Spain in March, is rapidly spreading across Europe. To establish the A222V variant involvement in the infection rise in Italy, all GISAID sequences from Italy and those from our Laboratory (Lazio) in the period June-October were analysed. A222V, first recognized in August, represents 11.2% of sequences in this period, reaching 100% of autochthonous sequences in October, supporting increased GV circulation in I...

10
Excellent negative predictive value (99.8%) of two rapid molecular COVID-19 tests compared to conventional RT-PCR for SARS-CoV-2 (COVID-19) in 2,011 tests performed in a single centre.
2021-06-21 infectious diseases 10.1101/2021.06.20.21258392
#1 (15.9%)
Show abstract

Conventional Reverse Transcription Polymerase Chain Reaction (RT-PCR) remains the gold standard for testing SARS-CoV-2. Since their availability, two rapid molecular COVID-19 tests were performed in parallel with RT-PCR in all urgent and emergency admissions, as the negative predictive value was not yet ascertained. In this study, we present the data of 2,011 test results using either ID Now COVID-19 (Abbott) (Abbott ID NOW) or Xpert Xpress SARS-CoV-2 (Cepheid) (GeneXpert) tests comparing to con...

11
The Comparison Of Three Real-Time PCR Kits For SARS-COV-2 Diagnosis Reveals Discrepancies On The Identification Of Positive COVID-19 Cases And Dispersion On The Values Obtained For The Detection Of SARS-COV-2 Variants
2021-07-16 infectious diseases 10.1101/2021.07.13.21260484
#1 (14.5%)
Show abstract

The COVID-19 pandemic has generated a huge challenge and threat to public health throughout the world population. Reverse transcription associated with real-time Polymerase Chain Reaction (RT-qPCR) has been the gold-standard molecular tool for diagnosis and detection of the SARS-CoV-2. Currently, it is used as the main strategy for testing, traceability, and control of positive cases For this reason, the on-top high demand for reagents has produced stock-out on several occasions and the only alt...

12
Evaluating the adequacy of Prima Covid-19 IgG/IgM Rapid Test for the assessment of exposure to SARS-CoV-2 virus
2020-06-03 infectious diseases 10.1101/2020.05.30.20117424
#1 (14.4%)
Show abstract

1.The outbreak of the SARS-CoV-2 in early 2020 found health authorities worldwide unprepared to control the pandemic. The adoption of accurate, rapid and inexpensive methods to identify infected subjects in the general population is of paramount relevance for the control of the disease. We evaluated one of the available serological tests, the Prima Lab Covid-19 IgG/IgM Rapid Tests, on 739 volunteers. We first assessed the tests reproducibility by administering it twice on the same day on 104 sub...

13
Investigation of Compatibility of SARS-CoV-2 RT-PCR Kits Containing Different Gene Targets During COVID-19 Pandemic
2020-06-19 infectious diseases 10.1101/2020.06.17.20133967
#1 (14.3%)
Show abstract

AimIn the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reverse transcriptase-polymerase chain reaction (RT-PCR) technique is often used. We evaluated the compatibility of SARS-CoV-2 RT-PCR kits containing different gene targets during the pandemic. Materials & methodsSamples were tested by Bio-Speddy(R) (RdRp gene) and Diagnovital(R) (RdRp+E genes). The correlation between two assays were determined by Deming regression and chi-square heatmap analyses. ResultsDiag...

14
Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site
2020-03-13 infectious diseases 10.1101/2020.03.10.20033944
#1 (14.1%)
Show abstract

The outbreak of COVID-19 become enormous threat to human beings, showing unclear virus mutation during dissemination. We found, in our 788 confirmed COVID-19 patients, the decreased rate of severe/critical type, increased liver/kidney damage and prolonged period of nuclear acid positivity, when compared with Wuhan. To investigate underlining mechanisms, we isolated one strain of SARS-CoV-2 (ZJ01) in mild COVID-19 patient and found the existence of 35 specific gene mutation by gene alignment. Fur...

15
Geographic reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase
2020-07-24 infectious diseases 10.1101/2020.07.23.20159871
#1 (13.9%)
Show abstract

The circulation of SARS-CoV-2 in Italy has been dominated by two large clusters of outbreaks in Northern part of the peninsula, source of alarming and prolonged infections in Lombardy region, in Codogno and Bergamo areas especially. The aim of the study was to expand understanding on the circulation of SARS-CoV-2 in the affected Lombardy areas. To this purpose, twenty full length genomes were collected from patients addressing to several Lombard hospitals from February 20th to April 4th, 2020. ...

16
Usefulness of quantitative Loop-Mediated Isothermal Amplification Assay in comparison with real time PCR for the diagnosis of invasive pneumococcal disease
2022-12-14 infectious diseases 10.1101/2022.12.12.22283380
#1 (13.9%)
Show abstract

BackgroundQuantitative LAMP (qLAMP) assay is one of the recent and emerging diagnostic tests for infectious diseases. Only a few studies exist comparing this assay with quantitative real-time PCR (qPCR) for the diagnosis of invasive pneumococcal disease (IPD). The present study was performed to compare the diagnostic performance of qLAMP assay with qPCR targeting autolysin gene for the diagnosis of invasive pneumococcal disease. Methodology/Principal FindingsNinety six blood samples and 73 CSF ...

17
Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.
2020-05-26 infectious diseases 10.1101/2020.05.22.20107292
#1 (13.8%)
Show abstract

The COVID-19 pandemic caused by SARS-CoV-2 is a public health problem unprecedented in the recent history of humanity. Different in-house real-time RT-PCR (rRT-PCR) methods for SARS-CoV-2 diagnosis and the appearance of genomes with mutations in primer regions have been reported. Hence, whole-genome data from locally-circulating SARS-CoV-2 strains contribute to the knowledge of its global variability and the development and fine tuning of diagnostic protocols. To describe the genetic variability...

18
Genomic Surveillance and Evolutionary Dynamics of Influenza A Virus in Sri Lanka
2024-08-23 infectious diseases 10.1101/2024.08.23.24312476
#1 (13.8%)
Show abstract

BackgroundInfluenza A has been named as a priority pathogen by the WHO due to the potential to cause pandemics. Genomic sequencing of influenza strains is important to understand the evolution of the influenza strains and also to select the appropriate influenza vaccines to be used in the different influenza seasons in Sri Lanka. Therefore, we sought to understand the molecular epidemiology of the influenza viruses in the Western Province of Sri Lanka, including mutational analysis to investigat...

19
Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection
2021-01-13 infectious diseases 10.1101/2021.01.08.20248771
#1 (13.6%)
Show abstract

SARS-CoV-2 RNA can be detected in respiratory samples for weeks or even months after onset of COVID-19 disease. Therefore, one of the diagnostic challenges of PCR positive cases is differentiating between acute COVID-19 disease and convalescent phase. Recently, the presence of SARS-CoV-2 nucleocapsid antigen in serum samples of COVID-19 patients was published [Le Hingrat et al. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing altern...

20
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients
2020-03-30 infectious diseases 10.1101/2020.03.28.20043059
#1 (13.6%)
Show abstract

Diagnosis is the key point for confirmation and treatment of COVID-19. we focused on comparative analysis of virus dynamics between the upper respiratory and feces specimens in the COVID-19 patients. A total of 66 upper respiratory swabs, 51 feces, 56 urine and 56 plasma samples were sequentially collected from 23 patients in a designated hospital. The plasma and urine samples were all negative, except for urine samples from two severe cases at the latest available detection point. Conversely, v...